|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense): | ||
| Interest income | ||
| Change in fair value of preferred stock tranche right liability | ||
| Total other income, net | ||
| Net loss before income taxes | ||
| Provision for income taxes | ||
| Net loss | ||
| Change in unrealized gains (losses) on investments, net of tax | ||
| Total other comprehensive income (loss) | ||
| Comprehensive loss | ||
| Net loss per share attributable to common stockholders, basic | ||
| Net loss per share attributable to common stockholders, diluted | ||
| Weighted-average common shares outstanding, basic | ||
| Weighted-average common shares outstanding, diluted |
Loading...
